
Customer stories
Clinical research is challenging. We're here to simplify it. Here's how we've helped our customers achieve success.
Together, we’re on a mission
Whether you’re working on the next breakthrough treatment, or a small team bringing big innovation to the industry, Medable is here for you every step of the way.

What clients are saying
Medable hired a third-party firm to get real feedback from customers across our trials. Here’s what they had to say about us.
Better compliance and faster study startup
A top-10 pharmaceutical company chose Medable to “reach a broader patient population” and found success in “increasing per-protocol data collection compliance” and “significantly reducing participant recruitment time.”
Increased oversight and scalability with eCOA and eConsent
A pharmaceutical group sought to overcome regulatory barriers and chose Medable for their “reliable DCT platform.” They found success in “increased scalability, simplified clinical trial experience, and better oversight.”
Greater insights paired with an easy to use system
A top-10 pharmaceutical company sought Medable to improve its participant engagement achieved “streamlined user experience, aggregated data for greater insights, and seamless integration into participants lives.”
.jpg)
Case Study
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly expand the number of oncology trials it could concurrently conduct.
“Our sites AND our teams are happy to report increased efficiency, reductions in ‘back and forth communication’, and less data entry.”
Top 5 Pharma
Accolades





The latest from Medable

Is Data Readiness Slowing Down AI in Clinical Trials? How Agentic AI Enables Immediate Impact
Most sponsors and CROs say their data isn't ready for AI. But agentic AI does not require a perfect data environment to begin delivering value. It can be deployed compliantly across siloed platforms, interpreting and reconciling differences in real time. In this 60-minute session, learn how AI agents deliver measurable value safely across clinical trials, reduce cognitive and operational burden, and enable teams to generate impact now while strengthening data foundations over time.


Eliminate clinical trial white space with the right AI strategy
It has become clear that our industry has reachedthe limits of human-only clinical development. As clinical trials have become increasingly complex, the endeavors that people alone can perform are no longer sufficient to generate the momentum needed to address the growing burden of human disease. This has led to longer drug development timelines and significant delays for patients. One large are of lost time is “white space,” definied simply as unproductive time caused by manual, sequential processes and fragmented data systems. Thankfully, a solution lies in agentic AI and its abilities to perform series of tasks.


More than a tool: How AI agents are transforming clinical trials |
Explore how agentic AI is transforming clinical trials by automating routine tasks and boosting team efficiency with real-world, low-risk use cases.


Medable Introduces Digital Data Flow Agent, Laying the Foundation for End-to-End Agentic Clinical Development
Medable introduces its Digital Data Flow Agent, transforming clinical trial protocols into machine-readable data to support adaptive, real-time clinical development.


Medable Launches Agentic Accelerator Program to Help Life Sciences Companies Deploy Agentic AI Across Clinical Development Lifecycle
High-touch enablement helps sponsors operationalize industry-specific agents to realize value faster.


Medable Introduces AI Agent to Reduce Burden at Research Sites by Assisting Principal Investigators with Oversight of eCOA Data
Medable Inc., the leading technology platform for AI-powered clinical development, today announced the launch of Agentic AI for research sites to reduce burden and assist principal investigators in oversight and monitoring of eCOA data.